We evaluated, in 1,800 patients with node-negative tumors treated with locoregional therapy until relapse, the competitive risks for different types of metastasis by cell proliferation (3H-thymidine labeling index [3H-dT LI]), estrogen receptors (ERs), and progesterone receptors (PgRs), and by the integration of biologic and clinicopathologic information.
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer / R. Silvestrini, M. G. Daidone, A. Luisi, P. Boracchi, M. Mezzetti, G. Di Fronzo, S. Andreola, B. Salvadori, U. Veronesi. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 13:3(1995 Mar), pp. 697-704-704. [10.1200/JCO.1995.13.3.697]
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer
P. Boracchi;
1995
Abstract
We evaluated, in 1,800 patients with node-negative tumors treated with locoregional therapy until relapse, the competitive risks for different types of metastasis by cell proliferation (3H-thymidine labeling index [3H-dT LI]), estrogen receptors (ERs), and progesterone receptors (PgRs), and by the integration of biologic and clinicopathologic information.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
